Course of lactate, pH and base excess for prediction of mortality in medical intensive care patients.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 30 09 2021
accepted: 04 12 2021
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 12 1 2022
Statut: epublish

Résumé

As base excess had shown superiority over lactate as a prognostic parameter in intensive care unit (ICU) surgical patients we aimed to evaluate course of lactate, base excess and pH for prediction of mortality of medical ICU patients. For lactate, pH and base excess, values at the admission to ICU, at 24 ± 4 hours, maximum or minimum in the first 24 hours and in 24-48 hours after admission were collected from all patients admitted to the Medical ICU of the University Hospital Tübingen between January 2016 until December 2018 (N = 4067 at admission, N = 1715 with ICU treatment > 48 h) and investigated for prediction of in-hospital-mortality. Mortality was 22% and significantly correlated with all evaluated parameters. Strongest predictors of mortality determined by ROC were maximum lactate in 24 h (AUROC 0.74, cut off 2.7 mmol/L, hazard ratio of risk group with value > cut off 3.20) and minimum pH in 24 h (AUROC 0.71, cut off 7.31, hazard ratio for risk group 2.94). Kaplan Meier Curves stratified across these cut offs showed early and clear separation. Hazard ratios per standard deviation increase were highest for maximum lactate in 24 h (HR 1.65), minimum base excess in 24 h (HR 1.56) and minimum pH in 24 h (HR 0.75). Lactate, pH and base excess were all suitable predictors of mortality in internal ICU patients, with maximum / minimum values in 24 and 24-48 h after admission altogether stronger predictors than values at admission. Base excess and pH were not superior to lactate for prediction of mortality.

Identifiants

pubmed: 34929006
doi: 10.1371/journal.pone.0261564
pii: PONE-D-21-31539
pmc: PMC8687550
doi:

Substances chimiques

Lactic Acid 33X04XA5AT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0261564

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Intensive Care. 2015 Oct 06;3:39
pubmed: 26445673
Tunis Med. 2019 Dec;97(12):1357-1361
pubmed: 32173805
PLoS One. 2018 Oct 5;13(10):e0205309
pubmed: 30289956
Am J Emerg Med. 2015 Sep;33(9):1134-9
pubmed: 26027886
Shock. 2016 Nov;46(5):480-485
pubmed: 27380535
Intensive Care Med. 2001 Jan;27(1):74-83
pubmed: 11280677
Resuscitation. 2014 Dec;85(12):1764-8
pubmed: 25447431
Crit Care. 2016 Aug 13;20(1):257
pubmed: 27520452
J Crit Care. 2011 Jun;26(3):316-20
pubmed: 21255970
Crit Care Med. 2018 Jun;46(6):e489-e495
pubmed: 29432347
Intensive Care Med. 2019 Jan;45(1):55-61
pubmed: 30478622
Ulus Travma Acil Cerrahi Derg. 2018 Nov;24(6):532-538
pubmed: 30516252
Crit Care. 2011;15(5):R242
pubmed: 22014216
PLoS One. 2020 Mar 9;15(3):e0229135
pubmed: 32150560
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Emerg Med Australas. 2020 Feb;32(1):20-24
pubmed: 31184442
Am J Respir Crit Care Med. 2010 Sep 15;182(6):752-61
pubmed: 20463176
J Crit Care. 2018 Apr;44:51-56
pubmed: 29065350
N Engl J Med. 2014 Dec 11;371(24):2309-19
pubmed: 25494270
Crit Care Med. 2004 Aug;32(8):1637-42
pubmed: 15286537
Crit Care Med. 2014 Sep;42(9):2118-25
pubmed: 24797375
Indian J Crit Care Med. 2018 Oct;22(10):697-705
pubmed: 30405279
Intensive Care Med. 2016 Feb;42(2):202-10
pubmed: 26556617
Crit Care Med. 2009 Oct;37(10):2827-39
pubmed: 19707124

Auteurs

Anja Schork (A)

Division of Endocrinology, Diabetology, and Nephrology, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.
Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
Department of Internal Medicine, Medical Intensive Care Unit, University Hospital Tübingen, Tübingen, Germany.

Kathrin Moll (K)

Department of Internal Medicine, Medical Intensive Care Unit, University Hospital Tübingen, Tübingen, Germany.

Michael Haap (M)

Department of Internal Medicine, Medical Intensive Care Unit, University Hospital Tübingen, Tübingen, Germany.

Reimer Riessen (R)

Department of Internal Medicine, Medical Intensive Care Unit, University Hospital Tübingen, Tübingen, Germany.

Robert Wagner (R)

Division of Endocrinology, Diabetology, and Nephrology, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.
Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH